Valuation: Getinge AB

Market Cap 5.63TCr 584.42Cr 510.95Cr 471.35Cr 433.29Cr 820.98Cr 56TCr 835.01Cr 2.21TCr 27TCr 2.19TCr 2.15TCr 95TCr P/E 2026 *
19.5x
P/E 2027 * 16.8x
Enterprise Value 6.49TCr 673.89Cr 589.18Cr 543.51Cr 499.62Cr 946.66Cr 65TCr 962.85Cr 2.55TCr 32TCr 2.53TCr 2.48TCr 1,09200Cr EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.7x
Free-Float
78.61%
Yield 2026 *
2.48%
Yield 2027 * 2.71%
1 day-13.69%
3 months-13.69%
6 months-18.09%
Current year-9.28%
Current year 20.05
Extreme 20.05
24.75
1 year 20.05
Extreme 20.05
24.75
3 years 15.62
Extreme 15.62
24.75
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
-13.69%-.--% - - 584.42Cr
+0.70%+0.45%+36.24%+1.88% 1.25TCr
+0.06%-5.56%+52.81%+25.99% 567.31Cr
+4.41%+12.81%-27.65%+20.94% 443.98Cr
+4.47%+5.32% - - 433.06Cr
+2.12%+6.89%-20.49%-22.62% 405Cr
-0.79%-2.17%-1.41%+251.17% 185.39Cr
+2.06%-4.92%-0.90%-59.48% 185.66Cr
-0.33%-0.33%+57.22%-3.17% 156.76Cr
+2.33%+2.05%-15.70%-45.05% 131.67Cr
Average +0.15%+0.95%+10.01%+21.21% 417.17Cr
Weighted average by Cap. -0.43%+0.89%+18.37%+13.94%

Financials

2026 *2027 *
Net sales 3.51TCr 364.38Cr 318.58Cr 293.88Cr 270.15Cr 511.87Cr 35TCr 520.62Cr 1.38TCr 17TCr 1.37TCr 1.34TCr 59TCr 3.69TCr 383.16Cr 335Cr 309.03Cr 284.08Cr 538.26Cr 37TCr 547.47Cr 1.45TCr 18TCr 1.44TCr 1.41TCr 62TCr
Net income 284.26Cr 30Cr 26Cr 24Cr 22Cr 41Cr 2.84TCr 42Cr 111.53Cr 1.39TCr 110.87Cr 108.44Cr 4.79TCr 330.9Cr 34Cr 30Cr 28Cr 25Cr 48Cr 3.31TCr 49Cr 129.84Cr 1.62TCr 129.06Cr 126.23Cr 5.57TCr
Net Debt 861.49Cr 89Cr 78Cr 72Cr 66Cr 125.69Cr 8.61TCr 127.84Cr 338.02Cr 4.21TCr 336Cr 328.64Cr 15TCr 662.21Cr 69Cr 60Cr 55Cr 51Cr 97Cr 6.62TCr 98Cr 259.83Cr 3.23TCr 258.28Cr 252.62Cr 11TCr
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,754
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
206.60SEK
Average target price
226.70SEK
Spread / Average Target
+9.73%

Quarterly revenue - Rate of surprise